Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Establishing Lymphedema and Fibrosis Measures in Oral Cancer Patients

NCT02412241 is registered in ClinicalTrials.gov with Vanderbilt-Ingram Cancer Center as lead sponsor.

NCT NCT02412241
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02412241 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Establishing Lymphedema and Fibrosis Measures in Oral Cancer Patients
Lead sponsor
Vanderbilt-Ingram Cancer Center
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2015
Completion date
August 31, 2020
Enrollment
118 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fibrosis, lymphedema, oral cavity cancer, oropharyngeal cancer